The effect of recombinant human erythropoietin on the development of retinopathy of prematurity

American Journal of Perinatology

Volumn 27, Issue 1, 2010, Pages 67-71

  Shah, Nishant ^a   Jadav, Pushkaraj ^c   Jean Baptiste, Dominique ^a   Weedon, Jay ^b   Cohen, Lourdes M ^c   Kim, M Roger ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c FLUSHING HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Erythropoietin; Recombinant; Retinopathy of prematurity; Very low birthweight infant

Indexed keywords

FERROUS SULFATE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; EYE EXAMINATION; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; TREATMENT DURATION; TREATMENT RESPONSE;

CASE-CONTROL STUDIES; ENDOTHELIN-1; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; NEOVASCULARIZATION, PHYSIOLOGIC; RETINOPATHY OF PREMATURITY; SEVERITY OF ILLNESS INDEX;

EID: 74549124890     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1224872     Document Type: Article

References (24)

1. Steinkuller P G., Du L, Gilbert C, Foster A, Collins M L., Coats D K. Childhood blindness. J AAPOS 1999 3 (1) 26-32
2. Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 1954 38 (7) 397-432
3. Smith L E., Shen W, Perruzzi C et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999 5 (12) 1390-1395
4. Morita M, Ohneda O, Yamashita T et al. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003 22 (5) 1134-1146
5. Donahue M L., Phelps D L., Watkins R H., LoMonaco M B., Horowitz S. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy. Curr Eye Res 1996 15 (2) 175-184
6. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996 37 (2) 290-299
7. Adamis A P., Shima D T., Tolentino M J. et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996 114 (1) 66-71
8. Goldberg M A., Schneider T J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994 269 (6) 4355-4359
9. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003 102 (4) 1340-1346
10. Carlini R G., Reyes A A., Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995 47 (3) 740-745
11. Ohlsson A, Aher S M. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006 (3) CD004863
12. Calhoun D A., Christensen R D., Edstrom C S. et al. Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol 2000 27 (3) 733-753
13. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984 102 (8) 1130-1134
14. Maier R F., Obladen M, Kattner E et al. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr 1998 132 (5) 866-870
15. Ohls R K., Harcum J, Schibler K R., Christensen R D. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997 131 (5) 661-665
16. Carlini R G., Dusso A S., Obialo C I., Alvarez U M., Rothstein M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 1993 43 (5) 1010-1014
17. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995 1 (10) 1024-1028
18. Türker G, Sarper N, Gökalp A S., Usluer H. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants. Am J Perinatol 2005 22 (8) 449-455
19. Brown M S., Barón A E., France E K., Hamman R F. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J AAPOS 2006 10 (2) 143-149
20. Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa A A. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 2000 159 (8) 627-628
21. Ohls R K., Ehrenkranz R A., Wright L L. et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001 108 (4) 934-942
22. Donato H, Vain N, Rendo P et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000 105 (5) 1066-1072
23. Williamson P, Griffiths G, Norfolk D, Levene M. Blood transfusions and human recombinant erythropoietin in premature newborn infants. Arch Dis Child Fetal Neonatal Ed 1996 75 (1) F65-F68
24. Hardy R J., Palmer E A., Schaffer D B., Phelps D L., Davis B R., Cooper C J. Outcome-based management of retinopathy of prematurity. Multicenter Trial of Cryotherapy for Retinopathy of prematurity Cooperative Group. J AAPOS 1997 1 (1) 46-54